Daily monitoring of pulmonary artery pressures with an implantable wireless sensor in patients with heart failure led to a 39% reduction in heart-failure-related hospitalizations, according to results from the CHAMPION randomized control trial. Trial results, which evaluated CardioMEMS' (Atlanta) heart failure patient measurement system, were published in the Feb. 9 edition of the Lancet. (Medical Device Daily)